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The APOBEC3 gene family plays a role in innate cellular immunity inhibiting retroviral infection, hepatitis B virus
propagation, and the retrotransposition of endogenous elements. We present a detailed sequence and population
genetic analysis of a 29.5-kb common human deletion polymorphism that removes the APOBEC3B gene. We developed
a PCR-based genotyping assay, characterized 1,277 human diversity samples, and found that the frequency of the
deletion allele varies significantly among major continental groups (global FST ¼ 0.2843). The deletion is rare in
Africans and Europeans (frequency of 0.9% and 6%), more common in East Asians and Amerindians (36.9% and 57.7%),
and almost fixed in Oceanic populations (92.9%). Despite a worldwide frequency of 22.5%, analysis of data from the
International HapMap Project reveals that no single existing tag single nucleotide polymorphism may serve as a
surrogate for the deletion variant, emphasizing that without careful analysis its phenotypic impact may be overlooked
in association studies. Application of haplotype-based tests for selection revealed potential pitfalls in the direct
application of existing methods to the analysis of genomic structural variation. These data emphasize the importance
of directly genotyping structural variation in association studies and of accurately resolving variant breakpoints before
proceeding with more detailed population-genetic analysis.
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Introduction
The APOBEC3 family is known to play a role in innate
cellular immunity against retroviral infection. The gene
family has undergone an expansion in primates, increasing
from a single copy in rodents to at least seven copies in
humans [1–3]. Among primates, the APOBEC3 family has been
subjected to strong and continuing selective pressures at the
amino acid level [3,4]. APOBEC3 proteins defend against
retroviruses by deaminating cytosine residues to uracil,
resulting in hypermutation and degradation of the viral
genome. Members of this gene family contain either one
(APOBEC3A and APOBEC3C) or two (APOBEC3B, APOBEC3F,
and APOBEC3G) conserved cytosine deamination domains
[1,2]. In addition to their role in innate retroviral immunity,
some APOBEC3 genes appear to inhibit hepatitis B virus
infection [5–8] and the retrotransposition of endogenous
elements [9–12]. It is thought that at least part of this activity
occurs through a deamination-independent mechanism [12].
Several recent studies have brought increased attention to
classes of genomic variation such as deletions, inversions, and
copy-number polymorphisms [13–20]. It is thought that these
variations contribute substantially to inter-individual ge-
nomic, and perhaps, phenotypic variation, but the structure
and population characteristics of these variants remain
largely unexplored. A deletion in the APOBEC3 gene cluster
was recently identiﬁed using two different approaches. The
deletion was ﬁrst discovered by mapping end-sequence pairs
from a human fosmid library against the human genome
reference sequence assembly [16]. A cluster of discordant
fosmid clones whose end-sequences mapped further apart
than the expected fosmid insert size predicted a deletion of
;30 kb near the APOBEC3B gene. Later, a second approach
conﬁrmed the deletion based on an interrogation of a dense
single nucleotide polymorphism (SNP) marker map gener-
ated as part of the International HapMap Project [17]. This
method discovered deletions by identifying clusters of SNPs
that showed apparent non-Mendelian inheritance, deviations
from Hardy-Weinberg equilibrium, or evidence of null
genotypes. Nevertheless, this variant was not detected in a
recent genome-wide screen of structural variation in the
HapMap populations using BAC or SNP-based microarrays
[20]. The availability of a fosmid clone that captured the
deletion event allowed us to sequence the structural variant
in its entirety and conﬁrm its presence. Precise sequence
deﬁnition of the deletion enabled the design of speciﬁc
genotyping assays across the deletion breakpoints. We
present here a sequence-based analysis of this deletion
polymorphism, a worldwide population survey of the deletion
frequency (1,277 DNA samples), and an analysis of the
surrounding haplotype structure. The results suggest this is
a functionally important structural variant that is stratiﬁed in
the human population.
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Sequence-Based Resolution of Deletion Breakpoints
We sequenced the entire insert of one of the fosmid clones
whose end-sequence pairs had initially identiﬁed the struc-
tural variant. Alignment of this sequence with the sequence
from the ﬁnishing human genome sequence assembly (hg17)
conﬁrmed the presence of a deletion overlapping the
APOBEC3A and APOBEC3B transcripts (Figure 1). Consistent
with non-allelic homologous recombination as the likely
mechanism of origin, the deletion breakpoints mapped to
two highly identical tracts of sequence: 350 bp in length,
100% sequence identity. In the deleted conﬁguration, a single
copy of this sequence exists and the 29.5 kb of sequence
between them is removed (position 37,683,131–137,712,716
on Chromosome 22 of hg17). The deletion removes the
genomic sequence between the ﬁfth exon of APOBEC3A and
the eighth exon of APOBEC3B, leading to a predicted full-
length functional hybrid transcript with a predicted amino
acid composition identical to APOBEC3A. Thus, individuals
possessing this structural variant would lack at least one copy
of the unique coding portion of APOBEC3B. Interestingly, the
predicted transcript would contain the 39 UTR from
APOBEC3B, but be subject to APOBEC3A upstream regulatory
signals.
Deletion Frequency
The availability of the complete sequence of the deletion
breakpoints allowed us to design PCR breakpoint assays
which distinguished insertion and deletion alleles (Figure 1
and Materials and Methods). We genotyped 1,007 individuals
from 51 populations included in the Centre d’Etude du
Polymorphisme Humain (CEPH) Human Genome Diversity
Panel (HGDP) and found that the deletion frequency was
highly variable (Figure 2). The deletion is rare in African and
European populations (frequency of 0.9% and 6%, respec-
tively), more common in East Asian and American popula-
tions (36.9% and 57.7%), and almost ﬁxed in Oceanic
populations (92.9%; Tables S1–S3). As a control against
potential SNPs under the PCR primer binding sites leading to
an overestimate of the frequency of homozygotes, we
reanalyzed all 127 samples initially scored as deletion
homozygotes with a second PCR assay targeted to the
insertion allele (see Materials and Methods). We reclassiﬁed
25 samples (19.6%) as hemizygous (Table 1). In order to rule
out further large-scale genotyping error, we calculated
estimates of Hardy-Weinberg equilibrium for each popula-
tion. No signiﬁcant deviations were observed.
FST Analysis
As a measure of population differentiation, we calculated
an overall FST value of 0.2843 for the APOBEC3B deletion in
Figure 1. Sequence Structure of Structural Variant and Genotyping Assay Design
(A) A fosmid clone containing the deletion variant was completely sequenced and compared to the human reference genome (insertion allele). The
deletion removes a 29.5-kb region spanning from the fifth exon of APOBEC3A (shown in red) to the eighth exon of APOBEC3B (shown in blue). The
deletion breakpoints map within identical 350-bp blocks (hatched shading) and the deletion is predicted to form a hybrid transcript. PCR assays were
designed to distinguish insertion and deletion alleles (short arrows show position of PCR oligonucleotides).
(B) PCR breakpoint genotyping assay. Genotyping results for 30 individuals are shown (lane 20¼negative water control lane). All homozygous deletion
events were confirmed by a second PCR assay designed to the insertion breakpoint (see Materials and Methods).
doi:10.1371/journal.pgen.0030063.g001
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Author Summary
Several recent studies have demonstrated that deletions, duplica-
tions, and inversions contribute a substantial fraction of the total
amount of variation present in the human genome. In this study, we
provide a comprehensive population-genetic analysis of a single
deletion previously identified by comparing the genome of a single
individual against the human genome reference sequence. Com-
plete genomic sequence spanning the deleted region was obtained,
allowing us to define the deletion breakpoints and develop a direct
genotyping assay. Analysis showed that the deletion removes a
member of a gene family involved in the innate immune response
against viral pathogens. We genotyped samples from a human
diversity panel and found drastic differences in the frequency of the
deletion around the world. Using data from the HapMap project and
the application of existing analysis techniques, we illustrate the
importance of directly genotyping this type of variation and of
clearly defining its boundaries. Without this level of detail the
potential functional importance of such variation may be missed.the HGDP. Large FST values are consistent with either
geographically restricted selection (local adaptation) or
demographic history (i.e., population bottlenecks and found-
er effects). To distinguish between these two possibilities, we
calculated an empirical FST distribution using 2,540 autoso-
mal SNPs and 207 small indels genotyped in individuals from
the same 51 populations [21,22]. Of the 2,747 loci, 52 had an
FST value greater than that obtained for the APOBEC3B
deletion, placing this deletion within the top 2% of the
empirical distribution. Estimates of FST may be sensitive to
allele frequency, so we repeated this comparison by only
considering the 635 loci that had a global minor allele
frequency between 0.17 and 0.27. A single SNP (rs2250341,
located in an intron of the PCP4 gene) of this subset had an
FST value greater than the APOBEC3B deletion, placing the
deletion in the top 0.16% of the frequency-matched
empirical distribution.
A striking feature of the deletion is the clinal increase in
frequency as one moves eastward away from Africa (Figure
S1). In order to further delineate this pattern, we repeated
this analysis using pairwise FST estimates between all possible
combinations of the 51 populations (Figure S2). The analysis
differentiates Oceanic, Amerindian, and some East Asian
populations from other human populations based on the
frequency of the deletion variant in comparison to other SNP
and indel loci in the same populations. This suggests that this
pattern is not solely the result of demographic history.
Linkage Disequilibrium and Haplotype Structure
We genotyped the individuals included in the HapMap
project: consisting of samples from the Yoruba people of the
Ibidan Peninsula in Nigeria (referred to as YRI), the CEPH
project in Utah (CEU), the Han Chinese population of Beijing
(CHB), and individuals of Japanese ancestry from the Tokyo
area (JPT); and searched for evidence of linkage disequili-
brium (LD) between the APOBEC3B deletion and ﬂanking
HapMap Phase I SNPs (Tables S4–S5). In contrast to other
deletion polymorphisms [17,19], we found no single SNP to be
in strong LD (r
2 greater than 0.8) with the deletion variant
(Figure 3). In the Yoruba sample there was one rare SNP with
an r
2 value of 0.663. This SNP, rs733107, has a minor allele
frequency of 0.025 with two of the three Yoruba deletion
Figure 2. Worldwide Frequency Distribution of APOBEC3B Deletion
Genotype frequencies from analysis of the HGDP (51 populations, Table S3) are overlaid on a map of the world. The deletion (black area of pie chart)
and insertion frequency (white) are depicted.
doi:10.1371/journal.pgen.0030063.g002
Table 1. REHH
Variant Information Proximal Distal
Population Allele Frequency REHH SNP Percentile Core Percentile REHH SNP Percentile Core Percentile
CEU I 0.933 0.3784 44.1% 35.2% 0.3119 51.9% 42.0%
CEU D 0.067 2.6429 48.4% 22.6% 3.2058 40.6% 16.4%
JPT þ CHB I 0.624 0.6054 67.2% 73.4% 0.3107 88.8% 94.3%
JPT þ CHB D 0.376 1.6518 32.8% 20.2% 3.219 11.2% 3.9%
YRI I 0.975 0.1242 20.7% 29.4% 0.0352 47.2% 44.1%
YRI D 0.025 8.0498 39.2% 7.4% 28.3933 2.0% 0.001%
REHH on each side of the variant locus in each population is given. The percent of HapMap Phase I SNPs or haplotype blocks of a similar frequency having equal or greater REHH values is
given for the insertion and deletion alleles in each of the populations.
doi:10.1371/journal.pgen.0030063.t001
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A Common Deletion Removes APOBEC3Bchromosomes carrying the minor allele. Interestingly, we also
found that no two-marker combination had an r
2 value
greater than 0.8 (the maximum values are 0.254 for CEU,
0.499 for JPT and CHB, and 0.661 for YRI). However, it
remains possible that more sophisticated multi-marker
approaches will be able to successfully tag the deletion
variant using existing SNPs. Unlike other regions of the
human genome, such as those enriched for complex
segmental duplications, the SNP density in this region
(approximately one SNP every 2.5 kb) is not signiﬁcantly
reduced. Since the deletion frequency shows drastic differ-
ences among the HapMap populations, the absence of a
suitable single marker tag is likely a consequence of a bias in
the ascertainment of SNPs typed in the HapMap panel.
Although no single SNP can act as a reliable proxy for the
variant, we noticed that the deletion appears to occur on a
common haplotype. Treating the deletion locus as a bi-allelic
variant, we constructed phased haplotypes using 21 HapMap
Phase II SNPs genotyped in all populations and located
within 25 kb of the deletion boundaries and performed a
haplotype network analysis (Figures 4 and S3; Tables S6 and
S7) [23] (http://ﬂuxus-engineering.com).
We identiﬁed 49 distinct haplotypes over this region.
Overall, 91% of the deletion events (YRI¼3/3, CEU¼8/8, and
61/68 of the JPT and CHB) lie on a single common haplotype
(haplotype 28) which differs from haplotype 31 only by the
presence of the deletion variant. Two additional haplotypes
are observed only for JPT and CHB deletion chromosomes:
haplotype 34 (n ¼ 4 chromosomes) and haplotype 29 (n ¼ 3
chromosomes) differ from haplotype 28 by a single nucleo-
tide difference. The former may represent an independent
occurrence of the deletion on haplotype 39 or a recombina-
tion event between haplotypes 39 and 29.
Extended Haplotype Homozygosity
In order to further investigate the unusual shared
haplotype structure and potential signatures of selection,
we assessed the deletion haplotype for evidence of extended
homozygosity [24,25]. We calculated extended haplotype
homozygosity (EHH), the relative extended haplotype homo-
zygosity (REHH), and the extended haplotype length (EHL)
for both the deletion and insertion alleles (Figures 5 and S4;
Tables 1 and 2). Without correcting for the decreased size of
the deletion haplotype, a potentially strong signal of local
adaptation indicated by a high frequency extended haplotype
for the deletion allele in Asia is observed (Figure 5B and 5C;
Table 3). Accounting for the physical reduction in chromo-
some size due to the deletion, however, largely eliminates this
signal in the Asian population (Table 2). Nevertheless, the
haplotype analysis does suggest weak signals of selection,
particularly in the Yoruba population.
Discussion
There are three important results of this examination of
the APOBEC3B deletion. First, the deletion occurs between
two asymmetric gene structures (APOBEC3B and 3A) and
produces a hybrid transcript whose putative coding sequence
maintains its frame. Despite the fact that the recombination
event occurs between coding exons, the amino acid sequence
of the hybrid gene is identical to APOBEC3A with the net
effect being complete loss of APOBEC3B and potential altered
regulation of APOBEC3A due to juxtaposition of novel 39
regulatory sequences. Second, the deletion variant shows
dramatic population stratiﬁcation with signiﬁcantly elevated
FST values observed for Eastern Asian, Oceanic, and Amer-
indian populations. The magnitude of the FST values
compared to a set of other genome-wide loci from the same
populations suggest that these observed frequency differ-
ences are not due to demographic history alone. Third, we
observe that no tag-SNP currently exists for this deletion. A
sophisticated, multi-marker tagging approach may success-
fully tag this allele, but this approach is complicated by the
observation that the major deletion haplotype (haplotype 28)
is identical to another haplotype (haplotype 31), except for
the presence of the insertion allele. Thus, despite the fact that
nearly 40% of the world’s population carries at least one copy
of this deletion, a suitable SNP surrogate does not yet exist. In
Figure 3. LD Flanking the Deletion Variant
LD (r
2) between the deletion locus (shaded box) and flanking Phase I HapMap SNPs is depicted for the YRI, CEU, and JPT þ CHB populations.
doi:10.1371/journal.pgen.0030063.g003
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A Common Deletion Removes APOBEC3Blight of its abundance, it is noteworthy that this variant was
not detected in a recent genome-wide screen of copy-number
variation in the human genome [20].
These data emphasize that the phenotypic impact of this
and potentially other structural variants may be overlooked
in association studies unless the structural variant is directly
genotyped. We also observed that potentially misleading
results can be obtained from the direct application of existing
haplotype-based methods for detecting selection to structural
variants. In our study, adjusting for the length of the
haplotype reduced the signiﬁcance of signals of selection
using EHL methods (Figure 5). This highlights the importance
of not only directly genotyping this type of variation, but of
also clearly resolving the breakpoints of the event. If genome-
wide screens for selection based on EHL are performed
without controlling for changes in the length of the genome
sequence, artifactual signals may be observed.
Our observations of the deletion architecture, the pop-
ulation frequency patterns, and the haplotype structure
indicate that variation at this locus may be important.
Analysis also revealed a weak, suggestive signal of selection
for the deletion. Since it appears that the deletion occurred
once and has since spread into other populations, a complete
understanding of the history of this locus would require
detailed knowledge of the different selective regimes and
demographic histories unique to these populations.
Until a more comprehensive population genetic theory is
developed and a phenotypic consequence of the deletion
event is demonstrated, one must be cautious about placing
too much emphasis on a potential selective advantage for the
deletion. Nonetheless, several possible scenarios may account
for the patterns observed at this locus. First, it is possible that
a 29.5-kb deletion of a gene may have altered the properties
of genetic recombination on this speciﬁc haplotype. Long-
range haplotype tests are highly sensitive to variance in
recombination rates among different haplotypes [25]. Sup-
pressed recombination could, in principle, retard LD decay
resulting in an underestimate of the allele’s age leading to
erroneous signals of recent selection. If this were the case,
one would expect a striking correspondence between long-
range haplotype-based signatures of selection [26] and the
more than 1,000 deletion polymorphisms that have now been
Figure 4. APOBEC3B Haplotype Structure
The deletion locus was coded as a bi-allelic variant, and phased haplotypes were constructed for the locus and all Phase II SNPs within 25 kb of the
deletion. The black bars identify haplotypes that carry the deletion allele while the white bars carry the insertion allele. The number of occurrences for
each haplotype is shown for all of the HapMap samples (A) and for each population separately (B).
doi:10.1371/journal.pgen.0030063.g004
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A Common Deletion Removes APOBEC3Bdocumented for the human genome [13–20]. Such a corre-
spondence has not yet been observed, although few structural
variants have been studied at this level of detail.
In a second scenario, the deletion may simply be a genetic
marker for another selective event that has occurred on this
speciﬁc haplotype (haplotype 28). In this model, the deletion
event is a genetic hitchhiker as opposed to the causative
allele. The APOBEC3 gene cluster has been subject to positive
selection at many different time points during human and
primate evolution [3,4,26]. Thus, a partial sweep of the
deletion variant could occur if individuals carrying this
speciﬁc haplotype had greater resistance to speciﬁc patho-
gens, perhaps as a result of amino acid changes in adjacent
members of the APOBEC gene family. In such a scenario,
however, the ﬁtness advantage would have to outweigh loss of
the APOBEC3B gene and the potential regulatory changes of
APOBEC3A incurred by the disruption to the surrounding
genomic region. A similar scenario has been put forward for
rearrangements associated with the alpha-globin gene family.
In this case, recurrent deletions of Hba1 and Hba2 associated
with alpha-thalassemia have risen to high frequency in
Mediterranean and Paciﬁc rim populations [27]. Data from
Papua New Guinea suggest that homozygous and hetero-
Figure 5. Impact of Deletion Size on EHH
(A) EHH and (B) REHH values are shown for the insertion allele (solid line) and deletion allele (dotted line) in the combined JPT and CHB HapMap
population. Distances are plotted based on the given SNP coordinates without accounting for the reduced size of the deletion haplotype. The extended
haplotype length for the deletion variant is compared to an empirical distribution obtained for (C) SNP haplotype blocks and (D) individual SNPs. The
comparison was made with SNPs or cores having a frequency between 0.35–0.40. The black arrow indicates the value obtained without correcting for
the reduced size of the deletion haplotype while the red arrow indicates the true EHL value for the deletion.
doi:10.1371/journal.pgen.0030063.g005
Table 2. EHL and the Impact of Shortened Deletion Haplotypes




CEU I 0.933 0.0833 6.9% 14.3%
CEU D 0.067 0.12947 14.8% 19.0%
JPT þ CHB I 0.624 0.08777 10.5% 34.1%
JPT þ CHB D 0.376 0.12849 8.5% 17.3%
YRI I 0.975 0.08439 5.5% 0%
YRI D 0.025 0.29757 1.0% 0.8%
The percent of HapMap Phase I SNPs or haplotype blocks of a similar frequency having
equal or greater EHL values is given for the insertion and deletion alleles in each of the
populations. EHL values for the deletion allele are corrected to account for the physical
shortening of the deletion haplotypes.
doi:10.1371/journal.pgen.0030063.t002
Table 3. Uncorrected EHL Values for Deletion Haplotypes
Population Frequency EHL (cM) SNP Percentile Core Percentile
CEU 0.0667 0.204532 5.3% 6.6%
JPT þ CHB 0.3764 0.203548 2.3% 2.9%
YRI 0.025 0.372637 0.4% 0.8%
Uncorrected EHL values that do not account for the physical shortening of the deletion
haplotypes are shown. Columns are as shown in Table 2.
doi:10.1371/journal.pgen.0030063.t003
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A Common Deletion Removes APOBEC3Bzygous genotypes confer protection against malaria and other
infectious disease [28]. A neutral deletion seems unlikely in
light of the conservation of this gene in humans and other
great ape species ([29] and J. M. Kidd, unpublished data).
Moreover, APOBEC3B has recently been shown to inhibit
replication of the hepatitis B virus, an observation that may
warrant further study in light of the frequency of this
deletion [8,30].
In a third scenario, the increased frequency of the deletion
could represent a shift in the balance of selective forces
impacting this locus. There may be a signiﬁcant cost
associated with the maintenance of active cytidine deami-
nases due to their mutagenic potential [3,31,32]. It has been
shown that APOBEC3B protein is present in the nucleus of
cells where it may act to repress retrotransposition in early
stages of development and in the germ line [8,9]. When the
threat posed by both endogenous and exogenous viral activity
is high, the protective properties offered by APOBEC3B may
outweigh the risks associated with its own activity. When rates
of endogenous viral activity are low and when changes in
environment reduce the presence of exogenous virus activity,
the detrimental effects associated with APOBEC3B may
outweigh its beneﬁt, resulting in strong selective pressure in
favor of the deletion. Similar arguments have recently been
proposed to account for the presence of an impaired allele of
the retroviral defense gene TRIM5a and is consistent with
evidence of increased retroviral activity in African but not
Asian apes [33,34]. When it comes to innate immune system
genes such as APOBEC3B, less truly may be more [35].
Materials and Methods
Sequencing and sequence analysis. A shotgun sequence assembly of
the fosmid insert containing the putative deletion was generated as
previously described [16]. Prior to sequencing, a ﬁngerprint map with
four independent restriction enzymes (EcoRI, HindIII, BglII, and
NsiI) conﬁrmed the ;30-kb deletion [36]. Deletion breakpoints were
identiﬁed by comparison of the fosmid insert sequence against the
human genome reference sequence assembly (hg17) using ClustalW
and BLASTN [37,38].
PCR genotyping assay. We designed PCR breakpoint assays to
distinguish the insertion and deletion alleles based on the following
oligonucleotide sequences: Deletion_F: TAGGTGCCACCCCGAT;
Deletion_R: TTGAGCATAATCTTACTCTTGTAC; Insertion1_F:
TTGGTGCTGCCCCCTC; Insertion1_R: TAGAGACTGAGGCCCAT;
and Insertion2_F: TGTCCCTTTTCAGAGTTTGAGTA; Inser-
tion2_R: TGGAGCCAATTAATCACTTCAT. Deletion primers are
speciﬁc to the deletion sequence conﬁguration and generate a 700-bp
PCR product upon ampliﬁcation. Insertion1 and Insertion2 primers
amplify only the insertion conﬁguration and produce 490- and 705-
bp products, respectively. Insertion and deletion PCR assays were
performed separately, the products pooled, and visualized on a
standard 1.5% agarose gel. PCR was performed in 17-ll reactions
composed of 0.85 ll of a 10-lM dilution of the forward primer, 0.85 ll
of a 10-lM dilution of the reverse primer, 8.5 ll of Qiagen (http://
www1.qiagen.com) PCR mastermix, and 50 ng of DNA. The following
cycling conditions were used: 5 min at 95 8C, followed by 40 cycles at
95 8C for 1 min, 60 8C for 1 min, and 72 8C for 1 min, followed by 7
min at 72 8C. Each individual from the HapMap was genotyped in
replicate with the Deletion and Insertion1 primers while each
individual in the HGDP was genotyped one time. In addition, each
of the samples, which appeared to be homozygous for the deletion,
were genotyped using a second set of oligonucleotides for the
insertion (Insertion2)
Human DNA samples. We genotyped 1,277 DNA samples
corresponding to 270 samples from the International Hap Map
project and 1,007 individuals from the CEPH HDGP [39,40]. Our
analysis from the HGDP includes individuals from 51 different
populations and excludes samples previously identiﬁed as duplicates
[21,41,42]. Eight individuals (numbers 993, 994, 1028, 1030, 1031,
1033, 1034, and 1035) belonging to South African Bantu populations
were genotyped (each was homozygous for the insertion) but were not
included in the analysis due to small sample size. Individual genotypes
are provided in Tables S1 and S4.
Haplotype construction. Phased SNP genotypes from HapMap
Phase I were used for LD and extended haplotype analyses (http://
hapmap.org). We excluded SNPs mapping within the deleted region
and used PHASE version 2.1 to infer new haplotypes which included
the insertion/deletion genotypes (http://www.stat.washington.edu/
stephens/software.html) [43,44]. We also constructed haplotypes for
insertion/deletion alleles based on the more complete Phase II
genotyping data using only SNPs genotyped in all populations (Table
S6).
Population genetic analysis. We used an exact test of Hardy-
Weinberg equilibrium for two-allele loci as implemented in version
1.2.0 of the R genetics package [45]. LD was measured by r
2. FST values
were calculated from population allele frequencies using an unbiased
estimator [46,47]. The calculated FST values were compared with an
empirical distribution deﬁned by a collection of SNPs and small
indels genotyped in the same individuals [21,22].
EHH, REHH, and EHL were calculated for the locus using SWEEP
(http://www.broad.mit.edu/mpg/sweep/index.html) version 1.0 [24].
EHH is the probability that two randomly chosen chromosomes
carrying the same allele at a core region are homozygous for all SNPs
to a deﬁned distance (x) from the core. REHH measures the decay of
EHH at a given core genotype compared to the decay of other core
haplotypes. SNPs mapping within the deleted region (ﬁve SNPs in
CEU and two SNPs each in JPT and CHB and YRI) were excluded for
all analyses of both the insertion and deletion cores. We measured
REHH values at a marker H of 0.04, which is a measure of the
observed amount of recombination and is roughly equal to a genetic
distance of 0.25 cM. Observed REHH values on each side of the core
were compared with REHH values calculated for each HapMap Phase
I SNP. EHL is operationally deﬁned as the sum of the genetic distance
at which EHH falls to 0.5 on either side of the core [48]. This distance
is sensitive to the density of markers, so SNP density was controlled
by matching to the density around APOBEC3 using SWEEP
(approximately one SNP every 2,500 bases). In this analysis, the core
haplotype was deﬁned as simply the insertion or deletion genotype.
Comparisons were made with an empirical distribution calculated
from HapMap Phase I data using two different deﬁnitions for the
core region. First, we deﬁned the core as the longest non-overlapping
haplotypes containing between three and ten SNPs [49]. Secondly, we
treated each SNP locus individually as a core. Resulting values were
then divided into 20 bins based on the core frequency (intervals of
5%), and the values corresponding to the insertion and deletion
alleles for each population were compared.
For the EHL analysis, haplotype length was measured in two ways.
For the insertion, the core was placed at the center of the variant
region, and EHL was calculated as the sum of the genetic distance at
which EHH fell to 0.5 on the proximal and the distal sides of the core.
The application of the same procedure to the deletion core results in
a misleading haplotype length since the corresponding haplotype on
deletion chromosomes is physically shorter due to the deletion. In
order to account for this, the haplotype length in the proximal and
distal directions was calculated separately by deﬁning each break-
point as the position of the core. This assures that the length of the
extended haplotype is not inﬂated by the inclusion of the
chromosomal segment which is actually deleted.
Supporting Information
Figure S1. Clinal Pattern of Allelic Variation
Deletion frequency is plotted against longitude to illustrate the
increased prevalence of the deletion moving eastward away from
Africa.
Found at doi:10.1371/journal.pgen.0030063.sg001 (60 KB PPT).
Figure S2. Pairwise FST Values
Pairwise FST values are indicated by the height of each peak. The
signiﬁcance of the FST values relative to an empirical distribution of
2,540 autosomal SNPs and 207 small indels is indicated by the peak
color. Yellow, top 10%; orange, top 5%; red, top 1%. Populations are
listed in the same order as in Table S3.
Found at doi:10.1371/journal.pgen.0030063.sg002 (2.7 MB TIF).
Figure S3. Haplotype Network
Haplotypes are numbered as in Figure 4. Yellow, haplotypes carrying
the insertion allele; black, haplotypes carrying the deletion allele.
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A Common Deletion Removes APOBEC3BFound at doi:10.1371/journal.pgen.0030063.sg003 (4.1 MB TIF).
Figure S4. EHH in YRI and CEU Populations
EHH and REHH values are shown for the Yoruba (A and B) and
European (C and D) populations. Distances are plotted based on the
given SNP coordinates without accounting for the reduced size of the
deletion haplotype. Solid line, insertion allele; dotted line, deletion
allele.
Found at doi:10.1371/journal.pgen.0030063.sg004 (1.4 MB TIF).
Table S1. Individual Genotypes from HGDP
Found at doi:10.1371/journal.pgen.0030063.st001 (131 KB XLS).
Table S2. Deletion Frequencies for Continental Groupings
Found at doi:10.1371/journal.pgen.0030063.st002 (30 KB DOC).
Table S3. Frequencies for Populations from the HGDP
Found at doi:10.1371/journal.pgen.0030063.st003 (87 KB DOC).
Table S4. Individual Genotypes from HapMap
Found at doi:10.1371/journal.pgen.0030063.st004 (36 KB XLS).
Table S5. Frequencies for Each HapMap Population
Found at doi:10.1371/journal.pgen.0030063.st005 (27 KB DOC).
Table S6. HapMap Phase II SNPs Used to Construct Haplotype
Networks
Found at doi:10.1371/journal.pgen.0030063.st006 (34 KB DOC).
Table S7. Deﬁnition of 49 Haplotypes Observed Over This Region
Found at doi:10.1371/journal.pgen.0030063.st006 (51 KB DOC).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession num-
ber for the fosmid sequence is AC192820. The sequences of
APOBEC3A (NM_145699.2) and APOBEC3B (NM_004900.3) were
obtained from GenBank.
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